back-button

    Erlotinib

    Information about Erlotinib

    Erlotinib uses

    Erlotinib is used in the treatment of pancreatic cancer and small cell lung cancer.

    How erlotinib works

    In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Erlotinib blocks this signal, and thus stops the production of these cancer cells.

    Common side effects of erlotinib

    Nausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema, Weight loss, Loss of appetite, Anemia, Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash

    Available Medicine for Erlotinib

    • ₹9514 to ₹11900
      Natco Pharma Ltd
      2 variant(s)
    • ₹9281 to ₹11157
      Zydus Cadila
      2 variant(s)
    • ₹18767 to ₹30570
      Glenmark Pharmaceuticals Ltd
      2 variant(s)
    • ₹5314 to ₹18990
      Dr Reddy's Laboratories Ltd
      2 variant(s)
    • ₹11000
      Intas Pharmaceuticals Ltd
      1 variant(s)
    • ₹11159
      RPG Life Sciences Ltd
      1 variant(s)
    • ₹7714 to ₹10395
      Alkem Laboratories Ltd
      2 variant(s)
    • ₹25500
      Lupin Ltd
      1 variant(s)
    • ₹9003
      Reliance Life Sciences
      1 variant(s)
    • ₹6500 to ₹8500
      United Biotech Pvt Ltd
      2 variant(s)

    Expert advice for Erlotinib

    • Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.
    • Erlotinib is not recommended for children and adolescents under 18 years of age.
    • Stop smoking and use effective contraceptive measures while on erlotinib treatment.
    • Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert’s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding.
    • Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.

    Frequently asked questions for Erlotinib

    Erlotinib

    Q. Is Erlotinib FDA approved?
    Yes, Erlotinib is approved by FDA
    Q. How long does Erlotinib work?
    A single dose of Erlotinib works for around 36 hours.
    Q. Is Erlotinib cytotoxic, chemotherapeutic drug, biologic or monoclonal antibody?
    Erlotinib is not a cytotoxic, chemotherapy drug, or monoclonal antibody. Erlotinib is a biologic tyrosine kinase inhibitor
    Show More
    Q. Does Erlotinib cause neutropenia?
    Yes, Erlotinib can cause neutropenia

    Content on this page was last updated on 02 May, 2017, by Dr. Varun Gupta (MD Pharmacology)